Media Inquiries
- (615) 322-NEWS Email
Latest Stories
- Vanderbilt University teams with StoryCorps to document community’s experience during COVID-19 pandemic
- Research Snapshot: New drug targets vascular inflammation, drastically improving the long-term effectiveness of vascular procedures
- Vanderbilt chemistry faculty named President of National Organization for the Professional Advancement of Black Chemists and Chemical Engineers
- Registration open for fall 2021 Undergraduate Creative Expression Showcase
- Strengthening Cybersecurity Across VU: Be aware of your digital footprint
With the peak of summer approaching, Vanderbilt researchers will discuss innovative research on melanoma and how new insights could lead to less toxic treatments and better outcomes for patients.
The discussion is part of the School of Medicine Basic Sciences’ monthly Lab-to-Table Conversation series. The event “Toward a Cure for Melanoma” will take place on Tuesday, July 27, at noon CT. Registration is required.
Moderated by Ann Richmond, Ingram Professor of Cancer Research and professor of pharmacology, the panel will feature:
- Justin Balko, associate professor of medicine and pathology, microbiology and immunology,
- Dr. Anthony Daniels, assistant professor of ophthalmology and visual sciences, cancer biology, and radiation oncology; chief of the Division of Ocular Oncology and Pathology,
- Dr. Doug Johnson, associate professor of medicine of hematology/oncology,
- Dr. Caroline Nebhan, clinical fellow in hematology/oncology.
